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Background: Smaug is an RNA-binding protein that induces the degradation and represses the translation of
mRNAs in the early Drosophila embryo. Smaug has two identified direct target mRNAs that it differentially regulates:
nanos and Hsp83. Smaug represses the translation of nanos mRNA but has only a modest effect on its stability,
whereas it destabilizes Hsp83 mRNA but has no detectable effect on Hsp83 translation. Smaug is required to
destabilize more than one thousand mRNAs in the early embryo, but whether these transcripts represent direct
targets of Smaug is unclear and the extent of Smaug-mediated translational repression is unknown.
Results: To gain a panoramic view of Smaug function in the early embryo, we identified mRNAs that are bound to
Smaug using RNA co-immunoprecipitation followed by hybridization to DNA microarrays. We also identified mRNAs
that are translationally repressed by Smaug using polysome gradients and microarrays. Comparison of the bound
mRNAs to those that are translationally repressed by Smaug and those that require Smaug for their degradation
suggests that a large fraction of Smaug’s target mRNAs are both translationally repressed and degraded by Smaug.
Smaug directly regulates components of the TRiC/CCT chaperonin, the proteasome regulatory particle and lipid
droplets, as well as many metabolic enzymes, including several glycolytic enzymes.
Conclusions: Smaug plays a direct and global role in regulating the translation and stability of a large fraction of
the mRNAs in the early Drosophila embryo, and has unanticipated functions in control of protein folding and
degradation, lipid droplet function and metabolism.Background
Post-transcriptional regulatory mechanisms that function
in the cytoplasm to control mRNA translation, stability
and subcellular localization play essential roles in a wide
variety of biological processes. While these types of con-
trols function in a variety of cell types, they are particularly
prevalent during early metazoan development where mRNAs
synthesized from the mother’s genome direct the early
stages of embryogenesis [1]. Indeed, genome-wide studies
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reproduction in any medium, provided the orembryos have highlighted the substantial role that cyto-
plasmic post-transcriptional regulation plays in early
embryos [1-13].
During early embryogenesis, regulation of specific tran-
scripts is achieved through cis-acting elements that represent
binding sites for microRNAs (miRNAs) or RNA-binding
proteins. For example, miRNAs induce degradation of spe-
cific transcripts in both zebrafish and Drosophila [3,10].
Similarly the RNA-binding protein Smaug plays a major
role in mRNA destabilization in the early Drosophila em-
bryo [9]. Smaug is the founding member of a conserved
family of post-transcriptional regulators that bind target
mRNAs through stem-loop structures, known as Smaug
recognition elements (SREs) [14-18]. SRE recognition by
Smaug family members is mediated by a sterile alpha motif
domain, which contains a cluster of conserved basic resi-
dues that functions as an RNA-binding surface [17,19-22].td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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bers repress translation and/or induce transcript decay
through their ability to recruit various factors to a transcript
[14-18,23,24]. For example, Drosophila Smaug can recruit
the Cup protein to an mRNA and Cup in turn interacts
with the cap-binding protein eIF4E [25]. The Cup-eIF4E
interaction inhibits translation by blocking eIF4E-mediated
40S ribosomal subunit recruitment. Smaug can also recruit
Argonaute 1 (AGO1) to an mRNA, thereby repressing
translation [26]. Typically, Ago proteins are bound to small
RNAs, such as miRNAs, that function to target the AGO1
protein to transcripts [27]. In contrast, Smaug can recruit
AGO1 in a miRNA-independent manner [26].
Smaug can also remove an mRNA’s poly(A) tail through
its ability to recruit the CCR4/NOT deadenylase [28-31].
In the case of at least one target mRNA this recruitment is
thought to involve a complex containing Smaug and the
Piwi-type AGO proteins Aubergine and AGO3 [32]. This
complex has been proposed to bind this target transcript
through SREs (bound by Smaug) together with sites com-
plementary to piwi-RNAs (piRNAs) that are bound to
AGO3 and/or Aubergine. Since the poly(A) tail plays a
role in both initiating translation and stabilizing an
mRNA, deadenylase recruitment can, in principle, both
block translation and/or induce transcript decay.
Smaug has two well-characterized target mRNAs, nanos
and Hsp83. Smaug represses nanos translation through
two SREs in the nanos 3′ untranslated region (UTR)
whereas loss of Smaug has only a modest effect on nanos
mRNA stability [14-16,28,33]. In contrast, Smaug induces
the degradation of Hsp83 mRNA through eight SREs in
the Hsp83 open reading frame, while having no detectable
effect on Hsp83 translation [28,31]. Thus, Smaug can dif-
ferentially regulate the expression of its target mRNAs.
nanos and Hsp83 mRNAs are localized to the posterior
of the embryo and Smaug’s regulation of these two tran-
scripts is intimately associated with their localization. nanos
mRNA is inefficiently localized to the posterior and nanos
mRNA that escapes the localization machinery is found dis-
tributed throughout the bulk of the embryo where it is
translationally repressed by Smaug [14-16,34,35]. nanos
mRNA localized to the posterior is not repressed by Smaug
and Nanos protein expression is thus restricted to the pos-
terior of the embryo. Hsp83 mRNA is uniformly distributed
in early embryos and, as embryogenesis proceeds, Smaug
degrades Hsp83 mRNA in the bulk cytoplasm of the
embryo while transcripts at the posterior of the embryo are
protected [28,31,36,37]. This degradation/protection mec-
hanism thus results in the localization of Hsp83 mRNA to
the posterior of the embryo.
In addition to nanos and Hsp83 mRNA, Smaug is likely to
regulate the expression of a large number of mRNAs in the
early embryo through direct binding. For example, genome-
wide experiments have shown that embryos collected fromhomozygous-mutant smaug females show stabilization of
approximately 1,000 transcripts [9]. In addition, smaug
mutant embryos also show cell-cycle defects associated
with a failure of DNA replication checkpoint activation
and they also fail to undergo zygotic genome activation
[11,15]. As neither of these phenotypes can be explained
by a defect in Smaug’s regulation of nanos or Hsp83, this
is consistent with a role for Smaug in regulation of the
expression of additional mRNAs.
To elucidate the global functions of Smaug in early
embryos we employed two genome-wide approaches:
1) RNA co-immunoprecipitations followed by microarray
analysis (RIP-Chip) to identify mRNAs that are bound by
Smaug and 2) polysome gradients coupled to microarrays
to identify targets of Smaug-mediated translational repres-
sion. Our data suggest that Smaug directly regulates the
expression of a large number of mRNAs in the early em-
bryo. Comparison of Smaug-bound mRNAs to those that
are translationally repressed by Smaug (identified in this
study), and those that are degraded in a Smaug-dependent
manner [9] suggest that two-thirds to three-quarters of
Smaug’s target mRNAs are either translationally repressed
or degraded by Smaug. We also find that Smaug regulates
the expression of multiple mRNAs that are localized to
the posterior of the embryo. Gene set annotation enrich-
ment analysis of the mRNAs directly bound by Smaug
suggests that it regulates a diverse array of processes in
the early embryo, including protein folding and degradation
as well as metabolism. We present data indicating that
Smaug regulates the expression of mRNAs encoding glyco-
lytic enzymes (hexokinase and phosophofructokinase), a
proteasome regulatory subunit (Rpn7) as well as epigenetic
(Su(z)12) and post-transcriptional (Bicaudal C) regulators.
Results
The mRNAs encoded by 339 genes associate with Smaug
To identify Smaug’s target mRNAs on a genome-wide
scale we used RIP-Chip. Extracts, prepared from 0- to
3-hour-old wild-type embryos, were immunoprecipitated
with an anti-Smaug antibody (hereafter denoted as
Smaug RIPs) while immunoprecipitations using non-
immune serum served as a negative control (hereafter
denoted as control RIPs). Genes that were not expressed
or were expressed at low levels in starting crude extracts
were removed from further analysis and Significance
Analysis of Microarrays (SAM) [38] was then used to
identify 339 genes whose mRNAs were significantly
enriched in Smaug RIPs compared to control RIPs at a
false discovery rate (FDR) of <5% (Figure 1; Additional
files 1 and 2). Importantly, this list contains both of the
well-characterized Smaug-target mRNAs, nanos and
Hsp83.
To verify the quality of our microarray data we used re-
verse transcription followed by quantitative polymerase
Figure 1 Identification of Smaug-bound mRNAs. The average,
across three biological replicates and one technical replicate, of the
microarray signal intensities of each expressed transcript in the Smaug
and control RIPs divided by the signal intensities of each transcript in
the immunoprecipitation inputs, were plotted against one another.
SAM analysis allowed for the identification of 384 transcripts (blue dots)
representing 339 genes that are enriched in the Smaug RIPs versus
control RIPs at an FDR of <5%. The dots representing Smaug’s two
known target mRNAs, nanos and Hsp83, are indicated. The dark dashed
line represents no enrichment and the light dashed diagonal lines
represent two-fold enrichment or depletion.
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cific mRNAs in Smaug RIPs compared to control RIPs.
Twelve selected mRNAs from the RIP-Chip target list
with FDRs <5%, including nanos and Hsp83, were
enriched in Smaug RIPs compared to control RIPs. In
contrast, four mRNAs that, based on our RIP-Chip data,
are not bound by Smaug showed little or no enrichment
(Figure 2).
The mRNAs encoded by 342 genes are translationally
repressed by Smaug
Smaug is a multifunctional regulator that is capable of
both repressing translation and inducing the degradation
of target mRNAs. To complement our identification of
the targets of Smaug-mediated mRNA decay [9] and our
identification of Smaug-bound mRNAs described above,
we employed polysome gradients coupled with microar-
rays to identify targets of Smaug-mediated translational
repression. This approach relies on the fact that the po-
sition of an mRNA in a polysome gradient is related to
the number of ribosomes associated with that mRNA
and can be employed to identify mRNAs that are regu-
lated at the level of translation initiation [39-41]. As a
first step towards applying this method we assessed the
position of polysome-bound and free ribosomes in ourgradients. Extracts prepared from 0- to 2-hour-old wild-
type embryos were applied to polysome gradients in the
absence or presence of EDTA. After centrifugation,
gradients were separated into 12 equal fractions and the
level of 18S rRNA in these fractions was determined via
northern blot (Additional file 3). In the absence of
EDTA, rRNA is distributed throughout the gradient,
consistent with the presence of both free and polysome-
associated ribosomes. In contrast, treatment with EDTA,
which disrupts polysomes, resulted in a shift of 18S
rRNA to the top fractions of the gradient. From these
analyses we concluded that fractions 7 to 12 are exclu-
sively polysomal, while fractions 5 to 6 are a mix of poly-
somal and non-polysomal material and fractions 1 to 4
are non-polysomal fractions. Subsequent gradients were,
therefore, divided into four unequal pooled fractions,
which, from the top to the bottom of the gradient were:
pool 1 (fractions 1 to 4) containing free mRNAs; pool 2
(fractions 5 to 6) containing a mix of free and polysome-
bound mRNAs; and pool 3 (fractions 7 to 9) and pool 4
(fractions 10 to 12), which both contain polysome-
associated mRNAs.
RNA from the resulting pools was extracted and used
to probe microarrays to assess the distribution of tran-
scripts within the gradient. To quantify the level of
translation for each gene we divided the average amount
of the corresponding mRNA in pools 3 and 4 by the
amount of mRNA in pool 1; and we define the transla-
tion index (TI) as the log2-transformed version of this
ratio. We removed genes from the polysome data that
were not expressed or were expressed at only low levels.
We also omitted the data from pool 2 in the TI calcula-
tion as it represents a mixed population of translated
and translationally repressed mRNAs. We note that
inclusion of pool 2 in the TI calculation has little effect
on the calculated TI (Additional file 4).
We then compared the TI for each gene in wild-type
embryos to previously published polysome/microarray
data from similarly staged wild-type embryos [8]. In that
previous study mRNA levels were assayed across poly-
some gradients divided into 12 fractions and genes
whose mRNAs were preferentially translated or prefer-
entially untranslated were identified. Figure 3 shows that
the TI calculated from our data is significantly higher for
the preferentially translated group of mRNAs compared to
the preferentially untranslated group (Wilcoxon rank-sum
test, P < 3 × 10-16), indicating an excellent correlation
between the two data sets.
To identify mRNAs that are translationally repressed
by Smaug, we fractionated extracts from embryos col-
lected from 0- to 2-hour old homozygous mutant smaug
mothers (hereafter denoted as ‘smaug-mutant embryos’).
We then compared the TI for each expressed gene in
wild-type and smaug-mutant embryos (Figure 4A; as
Figure 2 Validation of Smaug-bound mRNAs. The fold enrichment of mRNAs in Smaug RIPs versus control RIPs was determined via RT-qPCR
and normalized to the levels of RpL32 mRNA in the immunoprecipitated material. The red line indicates one-fold (that is, no) enrichment. Results
are the average of three independent experiments and error bars indicate standard error of the mean.
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tion has little effect on the calculated TI, see Additional
file 5). We expected the mRNA targets of Smaug-
mediated translational repression to shift their distribu-
tion from pool 1 in wild-type embryos to pools 3 and 4
in smaug mutant embryos, thus resulting in an increase
in those genes' TIs. Using SAM we identified 342 genes,
with an FDR of <5%, where the TI increased in smaug-Figure 3 Validation of polysome-gradient microarrays. TIs
calculated in this study were used to generate box plots to compare
the range of TIs for genes that were previously categorized in Qin et al.
[8] as ‘translationally active’ or ‘translationally inactive’ in embryos from
the same developmental stage.mutant embryos versus wild type (Figure 4A; Additional
files 6 and 7). These genes represent a high-confidence
list of Smaug-mediated translational repression targets.
As expected, neither Hsp83 nor nanos mRNA was
present in this high-confidence list: first, using metabolic
labeling, we previously showed that Smaug has no effect
on Hsp83 translation [28]; second, Clark et al. [42] have
shown that a substantial fraction of translationally repressed
nanos mRNA is associated with polysomes, consistent with
our observation that approximately 54% of nanos mRNA is
polysome-associated in wild-type embryos.
Targets of Smaug-mediated translational repression are
recruited to polysomes in a smaug mutant
To confirm that the increase in TI was indeed the result
of the recruitment of mRNAs onto polysomes, smaug-
mutant extracts were treated with puromycin, applied to
polysome gradients and the resulting fractions were then
analyzed via microarray. Puromycin is a translational
inhibitor that causes premature chain termination during
translation, thereby releasing mRNAs from polysomes.
Figure 4B shows that puromycin causes a significant
decrease in the TI (Fisher’s exact test, P < 3 × 10-16) for the
bulk of mRNAs present in smaug-mutant embryos (that
is, those genes whose mRNAs show a FDR >5%), consist-
ent with the fact that the majority of the mRNAs that are
present in pools 3 and 4 of our gradients are indeed
polysome-associated. Similarly, we also saw a significant
decrease in the TI (Fisher’s exact test, P < 3 × 10-16) for the
342 genes that are targets of Smaug translational repres-
sion (FDR <5%), consistent with the fact that, in smaug-
mutant embryos, these mRNAs are highly associated
with polysomes.
Figure 4 Identification of the targets of Smaug-mediated translational repression. (A) The averages, across three biological replicates, of
the TI in smaug-mutant and wild-type embryos were plotted against one another. SAM analysis allowed for the identification of 359 transcripts
(blue dots) representing 342 genes that show an increase in TI in smaug mutant versus wild type at an FDR of <5%, while the red dots represent
genes with FDRs of >5%. The solid diagonal line represents no enrichment and the dotted diagonal lines represent two-fold enrichment or
depletion. (B) Polysome gradients from smaug-mutant embryos were performed with or without puromycin treatment and the average, across two
biological replicates, of the TI for each gene was calculated. Box plots show the range of TIs for genes where the TI increased in smaug-mutant
embryos versus wild type with an FDR <5% and those with an FDR >5%, as defined in (A).
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3,000 mRNA targets
In addition to those genes that meet an FDR of <5%
(shown in blue in Figure 4A) the TI of a large number
of additional genes increased in smaug mutants. This
suggests that a substantial subset of the genes with >5%
FDR are potential targets of Smaug-mediated transla-
tional repression. Since SAM corrects for an average
change in TI, if a large proportion of transcripts were in
fact translationally repressed by Smaug, SAM would
over-correct, thereby increasing the number of false
negatives. To further evaluate the extent of Smaug-
mediated translational repression we generated lists of
genes that encode mRNAs that are unlikely to be bound
by Smaug and are, therefore, unlikely to be targets of
Smaug-mediated translational repression and then
assessed their behavior in the polysome-gradient micro-
array experiments. We did this by identifying the 250,
500 and 1,000 genes whose mRNAs showed the lowest
fold-enrichment in Smaug RIPs versus control RIPs. A
comparison of the TI for each of these genes in wild-
type and smaug-mutant embryos showed a distribution
with little bias towards an increase in TI in the smaug
mutant, confirming that few are likely to be targets of
Smaug-mediated translational repression (Figure 5A;
Additional file 8). In general, most genes not bound by
Smaug had TI changes below the median of the smaug
mutant (see Figure 5B where genes were ranked based
on the extent of the increase in TI in smaug-mutant ver-
sus wild type, with the gene having the highest increasebeing ranked number one). This trend is highly signifi-
cant (for example, 350 of the 500 ‘unbound’ list are
below the median and the distributions of the bottom
250, 500 and 1,000 genes are all significantly different
from the distribution for all genes; Fisher’s exact test,
P < 3 × 10-16).
Finally, we performed a kernel density estimation of
the change in TI for the genes whose mRNAs fell into
the top 250, 500 and 1,000 Smaug-bound transcripts
(that is, those mRNAs with the highest fold-enrichment
in Smaug RIPs compared to control RIPs) as compared
with the 250, 500 and 1,000 genes whose mRNAs were
unlikely to be bound by Smaug (that is, with the lowest
fold-enrichment in Smaug RIPs versus control RIPs).
This analysis showed a peak change of TI in smaug-
mutant embryos versus wild type of 1.57, 1.49 and 1.49
(linear fold-change of 2.97, 2.80 and 2.80) for each of the
top three sets of bound transcripts, respectively (Figure 5C;
Additional file 9). In contrast, for each of the unbound sets
there was a peak TI change of only −0.01, 0.10, and 0.12
(linear fold-change of 0.99, 1.07, and 1.09), respectively
(Figure 5C; Additional file 9). The fact that transcripts not
bound by Smaug had no change in TI, on average, sug-
gests that our TI estimates are directly comparable
between the smaug-mutant and wild-type datasets. As
such, the distribution of TI changes for all genes is consist-
ent with Smaug repressing the translation of a large num-
ber of mRNAs in the early Drosophila embryo.
To estimate the actual number of genes that are
translationally repressed by Smaug, we deconvolved the
Figure 5 Smaug represses the translation of thousands of mRNAs in the early embryo. (A) The 500 bottom Smaug binders are the 500
genes whose mRNAs show the lowest fold enrichment in Smaug RIPs versus control RIPs and they were plotted as in Figure 4A. The solid
diagonal line represents no enrichment and the dotted diagonal lines represent two-fold enrichment or depletion. (B) Genes were ranked based
on the extent of the increase in TI in smaug mutant versus wild type, with the gene having the highest increase being ranked number one. Box
plots were then used to show the range of ranks for all genes, and the bottom 250, 500 and 1,000 Smaug binders as defined in (A). (C) Kernel
density plot showing the change in TI in smaug mutant versus wild type for the bottom 500 Smaug binders as defined in (A) compared to the
top 500 Smaug binders and all genes in the data set.
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Additional file 9) to estimate the relative contributions
of genes whose TI changes are distributed according to
the top N and bottom N Smaug-binders (for N = 250,
500, and 1,000), respectively. Based on this analysis, we
estimated that 3,135, 3,094, or 2,728 are likely to be
translationally repressed by Smaug using the distribu-
tions for N = 250, 500, or 1,000, respectively (for details
see Materials and methods). We conclude that Smaug
represses the translation of approximately 3,000 mRNAs
in early embryos, representing about half of the 5,886
genes whose expression we detected in the polysome-
microarray data set.
SRE stem-loops are highly enriched in Smaug’s target
mRNAs
Smaug binds to and regulates its target mRNAs through
SRE stem-loop structures and, as such, we would expectthat mRNAs bound by Smaug as well as mRNAs trans-
lationally repressed by Smaug would be enriched for
these stem-loops. The consensus sequence for the SRE
loop is CNGGN0-3 (where N is any base) [17,20]. The
variability in the number of nucleotides at the 3′ end of
the loop derives from structural studies showing that
while the RNA-binding domain of the yeast Smaug
homolog, Vts1p, interacts with the loop and stem 5′ to
the loop, it does not make contact with the 3′ region of
the loop [20,22]. Thus, loop sequences where N is
greater than 3 at this position are also expected to be
Smaug-binding sites.
To ask whether SREs are predictive of Smaug binding
and translational repression we searched all expressed
genes in the RIP-Chip and polysome-microarray datasets
for stem-loops with the loop sequence CNGGN0-4 (see
Materials and methods for details). Our method assigned
a probability for each potential SRE within a transcript
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loop structure where the loop matches the CNGGN0-4
consensus. For each mRNA, an SRE score was then cal-
culated as the sum of the probabilities for each SRE
within that mRNA [43]. Strikingly, for the RIP-Chip ex-
periment, bound mRNAs (FDR <5%) had a median SRE
score of 25.9 whereas unbound mRNAs (FDR >5%) had
a 10-fold lower SRE score (2.4). Likewise, for the
polysome-microarray experiment, repressed mRNAs
(FDR <5%) had a median SRE score of 36.2 whereas un-
repressed mRNAs (FDR >5%) had a median SRE score
of only 3.9. Within each of the regulated sets, however,
the mRNAs nearer the top of the list (top 50 or top 100
as defined by fold-enrichment in Smaug RIPs versus
control RIPs for binding or the change in TI between
smaug-mutant and wild type for translational repression)
did not have higher SRE scores than the median for the
bound or repressed mRNAs with FDR <5%.
Next, again using fold-enrichment and change in TI as
metrics for binding and translational repression, respect-
ively, we employed multiple linear regression to simul-
taneously assess the possible contributions of stem-loops
carrying CNGGN0-4 loops along with six altered stem-
loops. The altered structures contained changes in the
invariant nucleotides in the CNGGN0-4 loop that are
predicted to lower their affinity for the Smaug RNA-
binding domain. We found that the bona fide SRE was a
significantly better predictor of both Smaug binding and
Smaug-mediated translational repression than any of the
altered stem-loops (Figure 6A). These results are con-
sistent with positive correlations between the presence
of sequences matching the SRE consensus within
mRNAs that are translationally repressed and/or
degraded in wild-type Drosophila embryos [44].
We next used these data sets to explore the predictive
power of other SRE features using the same approach.
We first tested SRE variants carrying different nucleo-
tides in the N2 position of the loop and found that
CUGG performed better than CGGG, CAGG and
CCGG loops, the latter three of which were similarly
predictive of both Smaug binding and translational re-
pression (Figure 6B). These data are largely consistent
with work suggesting that the yeast and human Smaug
homologs have binding preferences for SREs bearing
CUGG and CGGG loops over CAGG and CCGG
[43,45]. We next tested the preference for the nucleotide
immediately 5′ to the loop and found that, while A, C and
U performed similarly, G performed better (Figure 6C).
This result is consistent with the binding specificity deter-
mined for the yeast and human Smaug homologs [45-48].
Finally, we tested the effect of varying the SRE loop size
and found that loops of five nucleotides performed best of
all, with a gradual decrease in the predictive value of
shorter or longer loops (Figure 6D).Smaug co-regulates translational repression and
degradation of a large fraction of its target mRNAs
Smaug employs different mechanisms to regulate the ex-
pression of its two characterized target mRNAs, nanos
and Hsp83 [14-16,28,31,33]. To gain a panoramic view
of how Smaug regulates its target transcripts we com-
pared the data for Smaug binding and translational re-
pression from the current study to the data from our
previous, genome-wide analyses of Smaug-induced tran-
script decay [9]. For the first set of comparisons the
fold-enrichment of an mRNA in Smaug RIPs versus con-
trol RIPs was used as a metric for Smaug binding and
the change in TI between the smaug-mutant and wild
type was used as a metric for translational regulation.
We found that mRNAs requiring Smaug for their deg-
radation showed significantly higher levels of both
Smaug binding (Figure 7A; Wilcoxon rank-sum test, P <
3 × 10-16) and Smaug-mediated translational repression
(Figure 7B; Wilcoxon rank-sum test, P < 3 × 10-16) than
mRNAs whose decay is not regulated by Smaug. Using
these two measures we also found a genome-wide cor-
relation between Smaug binding and Smaug-mediated
translational repression (Spearman’s rho = 0.43, Fisher’s
exact test P < 3 × 10-16; Figure 7C).
We then compared the lists of genes whose mRNAs
are bound by Smaug to those that are degraded or trans-
lationally repressed by Smaug (Figure 7D). As described
above, our data suggest that several thousand mRNAs
are translationally repressed by Smaug and that the cal-
culated FDR overestimates the true FDR [49]. Thus, for
all comparisons involving polysome data we used a list
of genes whose mRNAs show an increase in TI in
smaug-mutant embryos versus wild type at an FDR
<10% rather than at <5%. This cutoff, often used in place
of 5%, is near an inflection point in the plot of gene
number versus FDR (Additional file 10), indicating that
there is a much higher, and fairly consistent, enrichment
for true positives up until that point.
We found that at least 67% of the mRNAs bound by
Smaug are targets of Smaug-mediated decay, while at
least 74% of the mRNAs bound by Smaug are transla-
tionally repressed by Smaug (Figure 7D). We also found
a substantial and significant overlap between the lists of
genes that encode mRNAs that are translationally re-
pressed by Smaug and those that require Smaug for their
degradation (that is, 71% of the mRNAs that are de-
graded by Smaug are also translationally repressed by
Smaug while 46% of mRNAs that are translationally re-
pressed by Smaug are targets of Smaug-mediated mRNA
decay; Figure 7D). A comparison of all three data sets
can be viewed in Additional file 11. Taken together,
these data indicate that a large fraction of Smaug’s tar-
gets are both translationally repressed and degraded by
Smaug.
Figure 6 SREs are enriched in Smaug-bound mRNAs and those that are translationally repressed by Smaug. Multiple linear regression
was used to simultaneously assess the contribution of various stem-loop structures to Smaug binding and Smaug-mediated translational repression.
Smaug binding was quantified using the fold enrichment in Smaug RIPs compared to control RIPs and Smaug-mediated translational repression was
quantified by comparing the TI in smaug-mutant versus wild-type embryos. The structures tested in (A) included a consensus SRE with the loop
sequence CNGGN0-4 while the other sequences tested carried the indicated changes in invariant positions of the loop that are predicted to reduce or
block Smaug binding. The structures tested in (B) included all possible nucleotides in the second position of the loop. The structures tested in (C) included
all possible nucleotides in the position that immediately precedes the loop. The structures tested in (D) included loops matching the CNGGN0-4 consensus
where the loop size varied from four to eight nucleotides. Error bars indicate standard error of the mean.
Chen et al. Genome Biology 2014, 15:R4 Page 8 of 21
http://genomebiology.com/2014/15/1/R4The comparisons from Figure 7D identified a substan-
tial number of genes that require Smaug for their deg-
radation or translational repression but do not appear to
be bound by Smaug. These transcripts may require
Smaug indirectly for their regulation or they may repre-
sent false negatives from the RIP-Chip experiments. To
assess the latter possibility, we grouped mRNAs into
four different classes where Smaug binders were defined
as having an FDR in RIP-Chip of <5% and the targets of
Smaug-mediated decay were based on the results ofTadros et al. [9]. The four classes were: 1) those mRNAs
that were bound by Smaug and required Smaug for their
degradation (‘bound + degraded’; Figure 8A); 2) those
that were neither bound nor degraded by Smaug (‘un-
bound + not degraded’); 3) those that were bound by
Smaug but did not require Smaug for their degradation
(‘only bound’); and 4) those that were not bound by
Smaug but did require Smaug for their degradation
(‘only degraded’). We then assessed the SRE scores for
the mRNAs in each of these groups and found a
Figure 7 Comparisons of Smaug-bound, repressed and degraded data sets. (A) Smaug binding was assessed using the fold enrichment in
Smaug RIPs compared to control RIPs and box plots were used to show the range of these enrichments for the targets of Smaug-mediated
mRNA decay and for non-targets. (B) Smaug-mediated translational repression was assessed using the change in TI in smaug-mutant compared
to wild type and box plots were used to show the range of these changes for the targets of Smaug-mediated mRNA decay and for non-targets.
(C) Smaug binding and translational repression were quantified as described in (A) and (B), respectively, and these values were plotted against
one another. The dashed vertical and horizontal lines represent the median values for Smaug binding and Smaug-mediated translational
repression, respectively. (D) Venn diagrams to show the overlap between the genes whose mRNAs are bound by Smaug, those that are degraded
by Smaug and those that are translationally repressed by Smaug (FDR <10%). Note that, for each comparison, only genes scored as ‘expressed’
in both data sets were included.
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the ‘only degraded’ class compared to the ‘unbound +
not degraded’ class (Figure 8A; Wilcoxon rank-sum test,
P < 3 × 10-16). Similar results were obtained for Smaug-
mediated translational repression (that is, a significantly
higher SRE enrichment for the ‘only repressed’ class of
mRNAs compared to the ‘unbound + not repressed’ class
of mRNAs (Figure 8B; Wilcoxon rank-sum test, P < 3 ×
10-16). Together these data suggest that a large fraction
of the mRNAs that require Smaug for their degradation
and/or translational repression that were scored asunbound in the RIP-Chip experiments are nonetheless
directly bound by Smaug.
The nanos mRNA’s SREs are found in the 3′ UTR
[14-16] and the Hsp83 mRNA’s SREs are found in the
open reading frame [28,31], raising the possibility that
the differential regulation of these transcripts relates to
SRE position. To assess this possibility we compared the
SRE scores for the 5′ UTR, open reading frame and 3′
UTR of genes that encode mRNAs that are translation-
ally repressed but not degraded by Smaug, degraded by
Smaug but not translationally repressed, and both
Figure 8 Smaug-degraded and Smaug-repressed mRNAs are enriched for SREs. (A) Genes were divided into one of four classes (see the
main text for more details): 1) bound and degraded by Smaug; 2) neither bound nor degraded by Smaug; 3) only bound by Smaug; and 4) only
degraded by Smaug. The range of SRE scores for these classes is shown in the box plots. (B) Genes were divided into one of four classes (see the
main text for more details): 1) bound and translationally repressed by Smaug; 2) neither bound nor translationally repressed by Smaug; 3) only
bound by Smaug; and 4) only translationally repressed by Smaug. The range of SRE scores for these classes is shown in the box plots. ‘All genes’
shows the range of SREs scores for all of the genes represented in (A) and (B), respectively.
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These results indicated that the vast majority of SREs
are localized within target transcripts’ open reading
frames and that SRE location within target mRNAs does
not explain their differential regulation by Smaug.
Subcellular localization of Smaug’s target mRNAs
Given Smaug’s role in controlling the subcellular distri-
bution and expression of localized mRNAs, we analyzed
the list of Smaug-bound mRNAs for subcellular
localization patterns reported by the Fly-FISH database
[6,50]. We searched for enrichment of the Fly-FISH
database categories defined in embryonic stages 1 to 3
and 4 to 5, representing the stages from which the
Smaug-regulated mRNAs were identified (Additional
files 13 and 14). The Fly-FISH database not only catego-
rizes subcellular localization patterns but also reports
whether an mRNA is degraded. Consistent with Smaug’s
role in transcript degradation, Smaug-bound mRNAs
were enriched for the Fly-FISH category ‘degraded’.
Additional highly enriched categories were those that
describe mRNAs that are localized to the posterior of
the embryo (for example, ‘posterior localization’, ‘pole
cell enrichment’ and ‘pole cell localization’). Together
the Smaug-bound mRNAs that fell into these categories
produced a collection of 44 genes, including nanos and
Hsp83, whose mRNAs are localized to the posterior. Ofthese 44 genes, 38 are regulated by Smaug at the level of
mRNA stability and/or translation (Additional file 15).
Functional analysis of Smaug-regulated mRNAs
To gain insights into Smaug’s biological functions in
early embryos we searched the list of Smaug-bound
mRNAs for encoded proteins with functions related to
known aspects of the smaug-mutant phenotype. Em-
bryos that lack Smaug show defects in the cell cycle that
are associated with a failure in DNA replication check-
point activation [11,15], suggesting that Smaug might
regulate the expression of genes involved in these pro-
cesses. Thus, we searched the list of Smaug-bound
mRNAs for genes that are annotated to play roles in the
cell cycle, checkpoint response and/or response to DNA
damage. We found a total of 32 such genes and enrich-
ment for the Gene Ontology (GO) term ‘cellular re-
sponse to DNA damage’. This list of genes included
cdc2c, mitotic 15 (mit(1)15), Replication Protein A 70
(RpA-70), Regulator of cyclin A1 (Rca1), Cyclin E (CycE),
Minichromosome maintenance 3 (Mcm3), CDC45L,
mutagen-sensitive 201 (mus201) and Msh6. Of these 32
genes, 29 are regulated by Smaug at the level of mRNA
stability and/or translation (Additional file 16).
Smaug also plays a prominent role in activating the
transcription of the zygotic genome in the early embryo
[11]. We thus searched the list of Smaug-bound mRNAs
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tion and/or chromatin and found a total of 25 genes, in-
cluding dre4, Polycomblike (Pcl), Nucleosome assembly
protein 1 (Nap1), Nucleosome remodeling factor - 38kD
(Nurf-38), anti-silencing factor 1 (asf1), Caf1-180, Caf1-
105, and vig2. Of these 25 genes, 24 are regulated by
Smaug at the level of mRNA stability and/or translation
(Additional file 17).
We also searched for novel functions of Smaug by
analyzing the Smaug-bound mRNAs via gene set anno-
tation enrichment analysis using the DAVID annotation
tool [51,52] applying two stringencies to the analysis: the
standard DAVID FDR cutoff of <10% and the more
stringent Benjamini-Hochberg FDR (P-value of <0.1).
These analyses suggest several previously unrecognized
roles for Smaug in the early embryo (Table 1).
First, Smaug may play a role in regulation of protein
folding. For example, Smaug-bound mRNAs encode five
proteins (Hsp60, T-cp1ζ, CG5525, CG8258 and CG7033)
that are members of the Chaperonin Cpn60/TCP-1 fam-
ily as defined by the Interpro database and are involved
in protein folding. The last four of these proteins are
subunits of the eukaryotic chaperonin TCP1-ring com-
plex (TRiC), also known as the chaperonin containing
TCP-1 (CCT), which consists of two rings composed of
eight different subunits [53]. Consistent with a role for
Smaug in regulating protein folding, all five of these
genes are regulated by Smaug at the level of translation
and/or mRNA stability (Additional file 18).
Second, Smaug-associated mRNAs are enriched for
the related GO terms ‘proteasome regulatory particle’
and ‘proteasome complex’ as well as the Protein Analysis
Through Evolutionary Relationships (PANTHER) term
‘ubiquitin proteasome pathway’. The ubiquitin prote-
asome system plays a vital part in a variety of cellular
processes through its role in the degradation of target
proteins. This mechanism involves the post-translational
addition of multiple ubiquitin moieties onto a protein,Table 1 Gene set annotation enrichment analysis results
for Smaug-bound mRNAs





FDR (P-value of <0.1)b
Cellular response to DNA damage √ -




Lipid droplet √ √
Oxidoreductase √ √
Glycolysis/gluconeogenesis √ -
aFor simplicity, terms with similar meanings are clustered or represented with
a single GO term, SwissProt keyword, or UniProt feature.
bEnrichment analysis was performed using the DAVID functional annotation tool.which, in turn, target the protein for proteasomal deg-
radation [54]. The 26S proteasome consists of a 20S core
particle, which carries the proteasome’s proteolytic activ-
ity, and either one or two 19S regulatory particles, which
are necessary for proteasome activity and are composed
of 19 subunits [54]. Strikingly, Smaug associates with
nine of the mRNAs that encode the regulatory subunits
(Regulatory particle triple-A ATPase 3 (Rpt3), Regulatory
particle triple-A ATPase 5 (Rpt5), Regulatory particle
non-ATPase 1 (Rpn1), Regulatory particle non-ATPase 2
(Rpn2), Regulatory particle non-ATPase 7 (Rpn7), Regu-
latory particle non-ATPase 9 (Rpn9), Regulatory particle
non-ATPase 10 (Rpn10), Regulatory particle non-ATPase
11 (Rpn11) and Regulatory particle non-ATPase 13
(Rpn13)). In contrast, Smaug does not interact with any
of the mRNAs that encode the 20S core particle pro-
teins. In addition, Smaug interacts with mRNAs that en-
code proteins involved in other aspects of the ubiquitin-
proteasome system (Ubiquitin activating enzyme 1
(Uba1), Ubiquitin fusion-degradation 1-like (Ufd1-like),
TER94 and CG9588). Consistent with a role for Smaug
in control of the ubiquitin-proteasome system, 12 out of
these 13 mRNAs (Additional file 19), including all of the
transcripts that encode regulatory subunit proteins, are
regulated by Smaug at the level of translation and/or
mRNA stability.
Third, Smaug might play a role in regulating lipid stor-
age and/or mobilization since the GO term ‘lipid drop-
let’ is enriched in the Smaug-bound mRNAs. Lipid
droplets are ubiquitous organelles that are found in a
wide range of organisms from bacteria to humans. They
consist of a neutral-lipid core composed of triacylglycer-
ols and sterol esters surrounded by a phospholipid
monolayer, and they serve as storage sites for energy,
sterols and membrane precursors [55]. Several studies
have used proteomic approaches to identify lipid
droplet-associated proteins, including two studies that
purified lipid droplets from Drosophila fat-body tissue or
from Drosophila embryos [56,57]. Comparison of those
lists with our data identified 33 Smaug-bound mRNAs
that encode lipid droplet-associated proteins. In
addition, our data indicated that 29 of these 33 mRNAs
are destabilized and/or translationally repressed by
Smaug (Additional file 20). Taken together these data
suggest that Smaug may control aspects of lipid droplet
function through its regulation of these mRNAs.
Fourth, a direct role for Smaug in regulation of metab-
olism is suggested by the enrichment for terms such as
the SwissProt keywords ‘oxidoreductase’ and ‘NAD’ and
the GO terms ‘oxidation reduction’ and ‘cofactor bind-
ing’ within Smaug-bound mRNAs. Together these lists
comprise a total of 37 metabolic enzymes that function
in a wide variety of pathways, including fatty acid metab-
olism, pyruvate metabolism, amino acid metabolism, the
Chen et al. Genome Biology 2014, 15:R4 Page 12 of 21
http://genomebiology.com/2014/15/1/R4citric acid cycle and oxidative phosphorylation. Our data
suggested that 28 out of 37 of these genes are regulated
by Smaug at the level of mRNA stability and/or transla-
tion (Additional file 21). In addition, we found enrich-
ment for the GO term ‘glucose metabolic process’ and
the Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway ‘glycolysis/gluconeogenesis’. These lists contain
nine genes, including four encoding enzymes of the
glycolytic pathway (Hexokinase A (Hex-A), Phosphoglyc-
erate kinase (Pgk), Phosphoglucose isomerase (Pgi) and
both genes encoding Glyceraldehyde 3 phosphate de-
hydrogenase (GAPDH1 and GAPDH2)) and our data in-
dicated that all nine are regulated by Smaug at the level
of stability and/or translation repression (Additional file
22). Furthermore, our data suggest that mRNAs encod-
ing four additional glycolytic enzymes may be regulated
by Smaug. Phosphofructokinase (Pfk) and Triose phos-
phate isomerase (Tpi) have FDRs in the RIP-Chip data of
5.15% and 6.08%, respectively, and both are targets of
Smaug-mediated transcript degradation and translational
repression (Additional file 22). Also, Enolase (Eno) and
Pyruvate kinase (Pyk) are regulated by Smaug at the
level of stability and/or translation. In summary, our
data suggest that 8 of the 10 glycolytic enzymes may be
regulated by Smaug.
Validation of Smaug’s role in regulation of target mRNAs
To assess the role of Smaug in regulating the expression
of the new target mRNAs, we selected five for further
analysis: Rpn7, Hexokinase, Phosphofructokinase, Su(z)
12, and Bicaudal C. Rpn7 is a proteasome regulatory
particle subunit and was selected because of the ob-
served enrichment for GO terms related to ‘proteasome
regulatory particle’. Likewise, because of enrichment for
the GO term ‘glucose metabolic process’ and the KEGG
pathway ‘glycolysis/gluconeogenesis’, we assayed hexoki-
nase, the first enzyme in glycolysis, and phosphofructo-
kinase, which represents a critical point of regulation
[58,59] and catalyzes the committed step of glycolysis
(that is, the product of this reaction serves solely as a
precursor to the final product of the glycolytic pathway).
Polycomb repressive complex 2 (PRC2) trimethylates
histone H3 on lysine 27, a mark that is associated with
transcriptional silencing [60]. Thus, Su(z)12, a compo-
nent of PRC2, was of interest in light of the failure to in-
duce zygotic transcription in smaug-mutant embryos
[11]. Bicaudal C is an RNA-binding protein that re-
presses the translation of target mRNAs during Drosoph-
ila oogenesis [61]. Thus, Bicaudal C overexpression in
smaug-mutant embryos could disrupt normal patterns of
post-transcriptional regulation.
Western blots (Rpn7, Su(z)12, Bicaudal C; Figure 9) or
enzyme activity assays (hexokinase, phosphofructoki-
nase; Figure 10) showed that, in all cases, there was anincrease in expression in smaug-mutant embryos versus
wild-type ones (Figures 9 and 10), consistent with a role
for Smaug in down-regulation of its new target
transcripts.
Discussion
Here we have used genome-wide approaches to identify
mRNAs that are bound by Smaug and those that are
translationally repressed by Smaug. Our results show
that the presence of SREs is predictive of both binding
and translational repression and, consistent with previ-
ous work on the yeast and human Smaug homologs
[43,45-48], indicate that the Drosophila SRE consensus
is more restricted than previously thought [17]. Integra-
tion of these new results with our earlier ones on
Smaug’s global role in mRNA decay [9] has led to the
following conclusions: 1) Smaug directly regulates the
expression of a large number of mRNAs; 2) a large frac-
tion of Smaug-regulated transcripts are both destabilized
and translationally repressed; and 3) Smaug plays a key
role in controlling the expression of mRNAs localized to
the posterior of the embryo. In addition, we have uncov-
ered new and unanticipated roles for Smaug in regula-
tion of protein folding and decay, as well as in
metabolism.
Translational repression versus mRNA decay
Previous work has firmly established that Smaug can
both repress translation and induce degradation of target
mRNAs. However, Smaug’s two well-characterized target
transcripts, nanos and Hsp83, are differentially regulated
by Smaug [14-16,28,31,33]. The work presented here
suggests that, unlike nanos and Hsp83, Smaug both
translationally represses and degrades a large fraction of
its target mRNAs. We hypothesize that the extent to
which Smaug regulates the translational repression and/
or destabilization of its targets is likely to be a conse-
quence of additional cis-elements within target mRNAs.
For example, the Hsp83 3′ UTR contains a translational
enhancer that may mitigate Smaug-mediated transla-
tional repression [62]. Similarly, the modest stabilization
of nanos mRNA observed in the absence of Smaug sug-
gests that additional cis-elements within the nanos tran-
script function in its destabilization.
Smaug’s role in the regulation of posterior-localized mRNAs
Smaug functions in the localization and regulation of its
target mRNAs at the posterior of the embryo
[14-16,28,31,34-37]. This is a consequence of Smaug’s
ability to induce transcript decay and to repress transla-
tion in the bulk cytoplasm of the embryo combined with
mechanisms that inactivate Smaug function in the germ
plasm at the posterior. Indeed, we have found that 38 of
the 44 posterior-localized mRNAs that are bound to
Figure 9 Validation of new Smaug targets. Extracts were prepared from 0- to 1-, 1- to 2- and 2- to 3-hour-old wild-type and smaug-mutant
embryos and assayed for the levels of (A) Rpn7, (B) Su(z)12 and (C) Bicaudal C proteins via western blots.
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A critical aspect of Smaug’s role in the regulation of
nanos and Hsp83 mRNA is the fact that transcripts
found at the posterior of the embryo escape Smaug
regulation. The molecular mechanisms that underlie this
spatial regulation of Smaug function are not understood,
but Oskar protein has been implicated in blocking
Smaug function at the posterior and has been shown to
physically interact with Smaug [14,15,36,63]. Indeed, it
has been shown that Oskar’s interaction with Smaug
blocks Smaug’s ability to bind to its target mRNAs and
it has therefore been proposed that the Oskar-Smaug
interaction blocks Smaug function by preventing
Smaug’s interaction with its target transcripts [30,64].
This simple model, however, is not consistent with work
showing that a torso mRNA carrying the first 96 nucleo-
tides of the nanos mRNA’s 3′ UTR, which includes one
of the nanos SREs, is repressed at both the anterior and
posterior of the embryo [14]. In addition, a torso mRNA
carrying the first 185 nucleotides of the nanos 3′ UTR,which contains both nanos SREs, is repressed at the an-
terior but is expressed at the posterior [65]. Taken to-
gether these data suggest the existence of one or more
cis-elements mapping within nucleotides 97 to 185 of
the nanos 3′ UTR that localize nanos transcripts to the
germ plasm [66] and/or abrogate Smaug’s ability to re-
press nanos mRNA expression in the germ plasm. Our
identification of several dozen posterior-localized,
Smaug-bound transcripts should facilitate identification
of any additional cis-elements.
Identification of new biological functions for Smaug
Our analysis of the mRNAs that are bound by Smaug has
identified a number of mRNAs that encode proteins that
are involved in cell-cycle control and transcriptional regu-
lation. Mis-regulation of one or more of these mRNAs
could underlie the cell-cycle and transcriptional defects
that occur in the absence of Smaug. Our data also suggest
that Smaug has several new and unanticipated biological
functions, including control of protein folding and degrad-
ation, lipid droplet function and basic metabolism.
Figure 10 Glycolytic enzymes are overexpressed in smaug-mutant embryos. Extracts were prepared from 0- to 1-, 1- to 2- and 2- to 3-hour
old wild-type and smaug-mutant embryos and assayed for (A) hexokinase activity or (B) phosphofructokinase activity. Activities are shown relative
to the wild type 0 to 1 hour time point in each case. Results are the average of three independent experiments and error bars indicate standard
error of the mean. Data were analyzed using a Student’s t-test (**P < 0.05, *0.05 < P <0.1).
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Our data suggest that Smaug downregulates the expression
of 9 of the 19 subunits of the proteasome regulatory particle
and 4 out of the 8 that encode the TRiC/CCT complex. In
addition, three of the four remaining TRiC/CCT mRNAs
and eight of the remaining ten proteasome regulatory par-
ticle mRNAs require Smaug for their degradation and/or
translational repression (Additional files 18 and 19). It is un-
clear at this time whether these additional mRNAs represent
false negatives in the RIP-Chip experiments or whether
Smaug regulates their expression indirectly. Nonetheless,
our data indicate that Smaug regulates the expression of al-
most all of the components of these two protein complexes.
Previous work has shown that proteasome levels are re-
pressed in early embryos [67] and our data suggest that
Smaug plays a major role in this repression. Given the role
of the proteasome in cell-cycle regulation [68], Smaug-
mediated regulation of the proteasome may underlie some
or all of the cell-cycle defects observed in smaugmutants.
Lipid droplets
Previous experiments to characterize lipid droplet-associated
proteins in embryos employed six independent purifications
and grouped the identified proteins based on the number
of purifications in which they were detected [57]. They
found 127 that were identified in at least three purifica-
tions and 453 that were identified in one or two runs. Of
the 28 Smaug-bound mRNAs that encode lipid-droplet
proteins, 22 were identified in three or more runs, suggestingthat Smaug regulates mRNAs that encode proteins abun-
dant in and/or tightly associated with lipid droplets.
Lipid droplets are storage sites of triacylglycerols, hy-
drolysis of which yields fatty acids that can be metabolized
for energy or serve as a source of membrane precursors.
Thus, lipid droplets could function as the source of mem-
brane precursors that are required during blastoderm cel-
lularization, a process during which plasma membrane
invaginates around the syncytial nuclei that are found at
the embryo’s periphery. A role for Smaug in regulating
lipid droplet function is intriguing as smaug mutant em-
bryos show defects in cellularization. In addition, given
the possible use of fatty acids as an energy source, Smaug’s
regulation of lipid droplet function could also reflect
Smaug’s more general role in control of metabolic pro-
cesses (see below).
Metabolism
Our data also suggest a widespread role for Smaug in regu-
lating metabolism in the early embryo, including a role for
Smaug in down-regulation of glycolysis. Previous work has
suggested that maternal mRNAs encoding the glycolytic
enzymes are present in early Drosophila embryos but are
rapidly degraded [69-75]. Glycolysis is down-regulated, not
only in Drosophila, but also in frog and mammalian early
embryos [76,77] but the molecular mechanisms involved
are unknown. Our data implicate Smaug in the degrad-
ation and/or translational repression of many of the
glycolytic mRNAs. It will be interesting to test whether
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homologs plays a role in the early embryos of all animals.
Biological implications of the large number of Smaug-target
mRNAs
Our data are consistent with Smaug directly regulating a
large number of mRNAs in early embryos through
translational repression and/or transcript degradation.
This raises the question as to whether all of these re-
pressive interactions are biologically important.
In one model only a subset of Smaug’s targets are bio-
logically relevant because the extent of downregulation
by Smaug varies in a target-dependent manner. For the
biologically relevant target transcripts, Smaug would ef-
fectively turn off their expression while, for the others,
Smaug would reduce their expression insufficiently to
have an effect on their biological function. A similar type
of model has been suggested for repression mediated by
individual miRNAs, which, as in the case of Smaug,
regulate the expression of a large number of transcripts
[78]. Given the low complexity of the binding sites of
most RNA-binding proteins it is likely that many of the
trans-acting factors that control mRNA translation and/
or stability will regulate a large number of transcripts
and, as such, the same concepts should apply.
An alternative, but not mutually exclusive, model is
that factors like Smaug, which repress the expression of
a large number of mRNAs, do so in order to limit the
total levels of available mRNA within a cell. This reduc-
tion could result from both Smaug-directed degradation
of transcripts and/or Smaug-mediated translational re-
pression, the former eliminating the mRNAs and the lat-
ter removing them from the pool of available mRNAs.
In this model, Smaug would function to control the
competition among transcripts for limiting cellular com-
ponents, such as the translation machinery. We note,
however, that our data do not support this model - at
least in regard to the translation machinery - as we fail
to see a decrease in the translation of mRNAs that are
not bound by Smaug in smaug-mutant embryos.
A third model to explain the biological significance of
the regulation of a large number of mRNAs by a single
factor relates to a requirement for large-scale changes in
a cell’s function. Under such a circumstance one might
expect that the expression of a large number of mRNAs
must be translationally repressed and/or degraded while
a new group of genes is activated. For example, during
the first 2 to 3 hours of Drosophila embryogenesis, nu-
clei are transcriptionally silent and development is
driven by mRNAs synthesized by the mother and depos-
ited into the egg during oogenesis. Subsequently, one- to
two-thirds of these maternal mRNAs are degraded
[4,9,12] - the majority in a Smaug-dependent manner -
concurrent with activation of transcription in embryonicnuclei. In the early embryo this widespread degradation
appears to serve at least two purposes. The first involves
clearing the embryo of mRNAs that are no longer re-
quired. In the second, ubiquitously distributed mRNAs
are degraded but locally protected from decay [28,37]
or are degraded everywhere and then subsequently re-
expressed in spatially restricted patterns through tran-
scriptional activation in select embryonic nuclei [4].
Thus, Smaug, through its regulation of a large number
of mRNAs, may play a major role in producing spatial
precision in gene expression during the maternal-to-
zygotic transition in early embryos.Conclusions
Smaug directly regulates the expression of a large num-
ber of mRNAs in the early Drosophila embryo and a sig-
nificant fraction of these mRNAs are both translationally
repressed and destabilized. Smaug plays a major role in
controlling the expression of mRNAs that are localized
to the posterior of the embryo and regulates a diverse
set of processes, including metabolism, lipid droplet func-
tion, protein folding and protein stability.Materials and methods
Drosophila stocks
Wild-type flies consisted of the w1118 stock maintained
in a large-scale Drosophila culture. smaug mutant alleles
included smaug1 [15] and smaug47. The smaug47 allele
was generated via imprecise excision of a P-element
(GE21229) using standard methods [79]. GE21229 is
inserted 2,499 bp 5′ of the smaug start codon and 20 bp
downsteam of the transcriptional start site of the smaug-
RB isoform. All isoforms are defined as described at
[80]. The original smaug1 allele showed homozygous
maternal effect lethality [15] and we recovered six exci-
sion lines demonstrating this phenotype. The extent of
the deletion in these six lines was determined via PCR
analysis of genomic DNA. Two of the lines, smaug30 and
smaug47, showed deletions removing large portions of
the smaug gene, but not affecting the neighboring up-
stream and downstream genes - CG5087 and CG5280,
respectively. Sequencing revealed that the smaug30 allele
is a 4,514 bp deletion of the smaug gene beginning
2,480 bp 5′ of and ending 2,034 bp 3′ of the smaug start
codon. Sequencing also showed that this allele retains
933 bp of the P-element. This deletion removes 2,020 of
2,997 bp of the open reading frame of smaug RA, RB,
RC, and RE isoforms. The smaug47 allele is a 5,542 bp
deletion beginning 2,483 bp 5′ of and ending 3,059 bp
3′ of the smaug start codon. This deletion leaves 39 bp of
the open reading frame in the smaug RA, RB, RC, and
RE isoforms.
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Embryos collected at 0 to 3 hours post-egglaying were
dechorionated with 50% bleach and homogenized in a
minimal volume of RIP lysis buffer (150 mM KCl, 20 mM
HEPES pH 7.4, 1 mM MgCl2, 1 mM dithiothreitol (DTT),
1× protease inhibitor cocktail (Bioshop, Burlington,
Ontario, Canada)). Extracts were centrifuged for 10
minutes at 4°C, and the supernatant was supplemented
with 9 M urea to a final concentration of 2 M. Protein A
beads were pre-incubated with either guinea pig anti-
Smaug antibody [9] or normal guinea pig serum followed
by four washes with RIP lysis buffer supplemented with
urea. These beads were then incubated with embryo ex-
tract for 2 h at 4°C followed by four washes with RIP lysis
buffer supplemented with urea and RNA was extracted
from the beads using the Trizol reagent (Life Technolo-
gies, Burlington, Ontario, Canada).
Polysome gradients
Embryos laid by wild-type or smaug1 homozygous
mothers were collected 0 to 2 hours post-egglaying,
dechorionated with 100% bleach and lysed in an equal
volume of polysome lysis buffer (7.5 mM MgCl2,
500 mM NaCl, 25 mM Tris pH 7.5, 2 mg/ml heparin,
0.5 mg/ml cycloheximide, 1 mM DTT, 50 U/ml RNasin,
1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydro-
chloride (AEBSF), 2 μg/ml leupeptin, 2 mM benzami-
dine, 2 μg/ml pepstatin A). Lysed samples were diluted 1
in 12.5 in polysome lysis buffer and 30% triton was
added to a final concentration of 1% and then spun at
6,000xg for 10 minutes and the resulting supernatant
was diluted in polysome lysis buffer supplemented with
1% Triton to an A260 of 12.5.
A 12 ml 15% to 45% linear sucrose gradient in 7.5 mM
MgCl2, 500 mM NaCl, 50 mM Tris pH 7.5 was created
using a BioComp Model 117 Gradient Mate gradient
maker (Biocomp, Fredericton, New Brunswick, Canada)
using a rotation angle of 80.5° and a rotation speed of
18 rpm for 1 minute and 58 seconds. After chilling the
polysome gradient on ice, 400 μl of diluted embryo ex-
tract was loaded onto the top of the gradient, which was
then spun at 36,000 rpm in a Beckman SW 41 Ti rotor
for 2.5 hours. The gradients were then separated into
four pools (pool 1 contained the top 4 ml, pool 2 con-
tained the next 2 ml, pool 3 contained the next 3 ml and
pool 4 contained the last 3 ml and the pellet). A fixed
amount of exogenous in vitro transcribed Arabidopsis
spike-in RNAs was then added to each pool. Our micro-
arrays contain probes that allow for the detection of
these RNAs allowing for subsequent data normalization.
We added 20% SDS, 0.5 M EDTA and 20 mg/ml pro-
teinase K to each fraction to final concentrations of
0.8%, 0.01 M and 0.128 mg/ml, respectively, and then in-
cubated them for 30 minutes at room temperature.Glycogen was then added to a final concentration of
80 μg/ml and samples were ethanol precipitated over-
night and the resulting pellet was washed with 75%
ethanol and resuspended in phenol-saturated water. Fol-
lowing two phenol-chloroform extractions, samples were
precipitated by the addition of 7.5 M LiCl to a final con-
centration of 1.5 M and an overnight incubation at 4°C.
The resulting pellet was washed with 75% ethanol, resus-
pended in water and ethanol precipitated in the presence
of 80 μg/ml of glycogen and 0.3 M sodium acetate. The
precipitate was then washed with 75% ethanol and re-
suspended in water. The integrity of RNA in each pool
was confirmed via northern blots, which were probed
for nanos mRNA (Additional file 23).
Experiments that utilized EDTA treatment involved
lysis of embryos in polysome lysis buffer and the result-
ing sample was split in two and the polysome gradient
experiment proceeded as described above with the fol-
lowing changes. One sample was diluted into polysome
lysis buffer and fractionated as normal, while the other
was diluted in polysome lysis buffer lacking MgCl2 and
containing 25 mM EDTA and fractionated on gradients
containing 25 mM EDTA and lacking MgCl2. After cen-
trifugation these gradients were divided into 12 1-ml
fractions and RNA was extracted from each fraction and
analyzed via northern blot.
For experiments that utilized puromycin embryos were
lysed in puromycin lysis buffer (50 mM Tris pH 7.5,
2 mM MgCl2, 500 mM KCl, 100 μM GTP, 1 mM DTT,
50 U/ml RNasin, 1 mM AEBSF, 2 μg/ml leupeptin,
2 mM benzamidine, 2 μg/ml pepstatin A). The lysed
samples were split in half and cycloheximide was added
to one sample to a final concentration of 0.5 mg/ml and
puromycin was added to the other sample to a final con-
centration of 2 mM. Samples were left on ice for 20 mi-
nutes and then incubated at 30°C for 10 minutes. Both
samples were then diluted 1 in 12.5 with polysome lysis
buffer supplemented with either puromycin or cyclohex-
imide and 30% triton was added to a final concentration
of 1%. The samples were then spun at 6,000xg for 10 mi-
nutes and the supernatant was diluted with polysome
lysis buffer supplemented with either puromycin or cy-
cloheximide to give an A260 of 12.5 and these diluted
samples were then fractionated as described above.
Microarrays
RNA samples from RIP experiments were used to pre-
pare single-stranded cDNA using anchored oligo(dT)
primers and the Canadian Drosophila Microarray Centre
indirect labeling protocol, which can be viewed at [81].
Anchored oligo(dT) primers consist of 20 T residues
and end in an A, C or G residue followed by an A, C, G
or T. Thus, priming occurs only at the 5′ end of the
poly(A) tail and transcripts with short tails will be
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tails. RNA samples from polysome experiments were
used to generate double-stranded cDNA following the
protocol described in the NimbleGen Array User’s Guide
(Gene Expression Arrays, version 5.0) using all reagents
at half the normal amount and a primer mixture of ran-
dom hexamer primers and anchored-oligo-dT primers.
Cy3 or Cy5-tagged random nonamers were then used to
label cDNAs using the Roche NimbleGen (Madison,
Wisconsin, USA) protocol. The cDNA resulting from
RIP experiments was used to probe Nimblegen 4x72K
arrays (Gene Expression Omnibus (GEO) platform num-
ber GPL13782), while the cDNA from polysome gradi-
ents was used to probe a custom-designed Drosophila
4x72K NimbleGen array (GEO platform number
GPL10539) that contain probes for Arabidopsis spike-in
RNAs (see below). Microarrays were scanned using Gen-
epix Pro software on a Molecular Devices (Sunnyvale,
California, USA) GenePix 4000B or 4300A scanner and
quantified using Nimblescan.
RIP microarrays were normalized using the Robust
Multi-array Average (RMA) quantile method and tran-
scripts that were expressed at levels significantly above
background in total RNA collected 0 to 3 hours post-
egglaying were determined using ‘one class unpaired ana-
lysis’ in SAM and transcripts with an FDR >5% were ex-
cluded from further analysis of the RIP data. mRNAs that
were reproducibly enriched in Smaug RIPs versus control
RIPs were then identified by comparing the log2(Smaug
IP/Total RNA) and the log2(Mock IP/Total RNA) using
‘two class unpaired analysis’ in SAM (FDR <5%).
Polysome microarrays were normalized using the
RMA quantile method. We further normalized the data
using Arabidopsis spike-in RNAs. The hybridization sig-
nals from the spike-in RNAs were utilized by applying a
linear transformation to each sample with the parame-
ters, a and b, determined by fitting the linear function
Y = aX + b using the spike-in signal, where X is the ex-
pression level of the spike-in RNAs in a specific sample,
and Y is the mean expression level of the spike-in
RNAs across all the samples. The genes significantly
expressed in wild-type or smaug-mutant embryos in
each of pools 1, 2, 3 and 4 were separately determined
using ‘one class unpaired analysis’ in SAM (FDR <5%).
We defined the genes significantly expressed in the
wild-type and smaug-mutant embryos as the union of
the significantly expressed genes from the four fractions
derived from that genotype. We then compared these
two lists and defined their intersection as the list of
genes significantly expressed in both wild-type and
smaug-mutant embryos, and restricted all the following
analysis to the genes on this list. To determine the list
of genes with different polysome association in wild-
type and smaug mutants, we compared the geometricmean of the expression level in pools 3 and 4 (normal-
ized to the levels in pool 1) in wild-type and smaug-
mutant embryos, using ‘two class unpaired analysis’ in
SAM.
RT-qPCR
cDNA was synthesized using SuperScript II reverse tran-
scriptase (Invitrogen) and random primers according to the
manufacturer’s instructions. Quantitative PCR reactions
were carried out using the BioRad (Mississauga, Ontario,
Canada) Real-time PCR system as per the manufacturer’s
instructions. Levels of RpL32 mRNA in each immunopreci-
pitated sample were used to normalize the levels of the ex-
perimental mRNA in that sample.
Estimating the number of genes that are translationally
repressed by Smaug
The fraction of genes expected to have changed in TI in
smaug-mutant and wild-type embryo samples for the top
N and bottom N Smaug-binders (for N = 250, 500, and
1,000) was calculated using the R (version 2.14.1) algo-
rithm sm.density() in the sm package (version 2.2-4.1).
The sm.density() algorithm provided smoothed density es-
timates for 100 values of change in TI for the top and bot-
tom N binders, with the 100 values calculated by the sm.
density() algorithm with each smoothed density estimate.
For every gene expressed in our polysome gradient ex-
periments, the probability that it was a positive target
(that is, a target of Smaug-mediated repression) was esti-
mated using the top N and bottom N Smaug-binders
(for N = 250, 500, and 1,000). First, for each gene, the
density of its change in TI under the positive and nega-
tive distributions as defined by N top and bottom
binders, respectively, was set to be equal to that of the
closest grid point higher than the change in TI. We then
estimated the probability that a gene was a positive by
taking the ratio of its density under the positive distribu-
tion and the sum of its densities under the positive and
negative distributions. This procedure was repeated for
each of our three sets of positive and negative distribu-
tions to give us three different sets of probabilities. For
each of these three sets of probabilities, we estimated
the expected number of Smaug targets for that set by
summing the ‘positive probabilities’ for all genes.
Smaug recognition element searching
We used a two-step procedure to computationally pre-
dict SRE stem/loops carrying the loop sequence
CNGGN0-4 on a non-specific stem. First, we performed
an initial scan using RNAplfold (version 2.0.7) [82] with
the parameters set to -W = 170, -L = 120, -T = 25
choosing these parameter values as they were within the
range suggested by Lange et al. [83]. Potential SREs for
further analysis were identified as CNGG sequences
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was involved in a canonical base pair with one of five
nucleotides immediately 3′ to the CNGG sequence with
probability >0.01. We estimated the probability of for-
mation of an actual SRE (that is, CNGG at the 5′ end of
the hairpin loop and a loop of length four to eight nu-
cleotides) at each candidate site using the RNAsubopt
[84] routine from the Vienna RNA package. In particu-
lar, we sampled 3,000 structures for each of a series of
windows overlapping the candidate site (from the Boltz-
mann ensemble using the ‘-p’ option), computed the
empirical probability of SRE formation in each window,
and set the SRE probability for a site to be the average
of these probabilities. The most 5′ of the sequence win-
dows spanned 75 nucleotides upstream of the candidate
site, the site itself, and the 40 nucleotides downstream
of the site. The most 3′ of the windows spanned 40 nu-
cleotides upstream of the site to 75 nucleotides down-
stream. Between these two, all of the other windows
were offset by a single nucleotide. These site probabil-
ities were then summarized at the transcript level. The
initial SRE score for each transcript was the sum of the
SRE probability values at each candidate site within the
entire transcript. The same procedure was used to
search for CNGG sequence variants and calculate a
variant score for each transcript. Once obtained, SRE
scores and the scores of sequence variants were com-
pared with polysome and RIP data using standard R
packages. Spearman’s correlation values across all of the
expressed genes were determined using the cor.test() al-
gorithm with default parameters and the Spearman
method. Linear models were created using the lm() al-
gorithm with default parameters.
Localization pattern enrichment analysis
These analyses were carried out as described in
Laver et al. [85].
Western blots
Antibodies against Rpn7 (Santa Cruz Biotechnology,
Dallas, Texas, USA; catalogue #SC-65750), Su(z)12 [86]
and Bicaudal C [87] were used in standard western blot
assays.
Glycolytic enzyme assays
For enzyme assays smaug-mutant embryos were col-
lected from females homozygous for the smaug47 allele,
while 'wild-type' embryos were collected from females
homozygous for the smaug47 allele that were also homo-
zygous for a genomic smaug rescue transgene that was
inserted at the attP40 site on the second chromosome
by Genetic Services (Cambridge, Massachusetts, USA)
using PhiC31 integrase-mediated transgenesis [88]. The
smaug transgene, which rescues the smaug mutantphenotype, is a modified version of a previously gene-
rated smaug rescue construct [15] that expresses a
version of Smaug that is tagged at its amino terminus
with FLAG and p53 epitope tags.
For the hexokinase assay, embryos were homogenized
in extraction buffer (0.05 M Tris–HCl, pH 8.0 with
13.3 mM MgCl2) and assayed in extraction buffer sup-
plemented with 16.5 mM ATP, 20 mM beta-NADP
and 0.67 M glucose. Hexokinase catalytic activity was
measured by adding Leuconostoc mesenteroides glucose-
6-phosphate dehydrogenase (Sigma-Aldrich Chemicals,
Oakville, Ontario, Canada; Worthington code ZF or ZFL)
dissolved at a concentration of 300 IU/ml in extraction
buffer. The production of beta-NADPH was monitored at
340 nm in a Thermo SPECTRONIC spectrophotometer.
Experiments were conducted with an amount of embryo
extract that was in the linear range of the assay and enzyme
activity was normalized to protein concentrations in each
homogenate measured using the Bradford assay (BioRad).
Enzyme activity was calculated using the formula: Units/
mg protein =ΔA340/minute ÷ 6.22 ×mg enzyme/ml reac-
tion mixture, as described by Worthington [89].
For phosphofructokinase assays, we used the Phospho-
fructokinase activity colorimetric assay kit (BioVision,
Milpitas, CA, USA), which converts fructose-6-phosphate
and ATP to fructose-diphosphate and ADP. The final
product, NADH, reduces a colorless probe to a colored
product with strong absorbance at 450 nm. The absorb-
ance was measured with a TECAN INFINITE m200 mi-
croplate reader. Experiments were conducted with an
amount of embryo extract that was in the linear range of
the assay and enzyme activity was normalized to protein
concentration.
Data access
The data reported in this study have been deposited in
NCBI’s GEO [90]. The RIP-Chip data are accessible
through GEO series accession number GSE49943 and
the polysome-microarray data are accessible through
GEO series accession number GSE50026.
Additional files
Additional file 1: A table listing replicate-to-replicate comparisons
of transcript microarray signal intensities from RIP-Chip
experiments.
Additional file 2: A table listing the genes that encode Smaug-bound
mRNAs (that is, genes with an FDR <5% in RIP-Chip experiments).
Additional file 3: A figure showing northern analysis of the
distribution of 18S ribosomal RNA in polysome gradients run with
or without EDTA.
Additional file 4: Comparison of wild-type TIs calculated with and
without data from pool 2.
Additional file 5: Comparison of the change in TIs in smaug-mutant
versus wild type with and without data from pool 2.
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of transcript microarray signal intensities from wild-type polysome
gradients, smaug-mutant polysome gradients, and smaug-mutant
polysome gradients with or without puromycin.
Additional file 7: A table listing the genes that encode mRNAs that
are translationally repressed by Smaug (that is, genes with an
FDR <10% in polysome-gradient microarray experiments).
Additional file 8: A figure comparing the TIs of the bottom 250,
500 and 1,000 Smaug binders in wild-type and smaug-mutant
embryos.
Additional file 9: A figure showing the kernel density plots comparing
the change in TI in smaug-mutant versus wild-type embryos of the
top and bottom 250, 500 and 1,000 Smaug binders.
Additional file 10: A figure showing the FDR-based rank of genes
from the polysome gradient-microarrays.
Additional file 11: The simultaneous overlap between the Smaug-
bound mRNAs and those mRNAs that are regulated by Smaug at
the level of translational repression and degradation.
Additional file 12: Cumulative density plots that show the SRE
scores for the 5′ UTR, open reading frame and 3′ UTR of Smaug-
target mRNAs that are translationally repressed, degraded and both
repressed and degraded.
Additional file 13: A table listing the Fly-FISH degradation categories
and localization patterns enriched among Smaug-bound mRNAs.
Additional file 14: A figure showing the Fly-FISH degradation
categories and localization patterns enriched among Smaug-bound
mRNAs.
Additional file 15: A table listing the genes that encode Smaug-bound
mRNAs that are localized to the posterior of the embryo.
Additional file 16: A table listing the genes that encode Smaug-bound
mRNAs that are annotated as having roles in cell cycle, checkpoint
response and/or response to DNA damage.
Additional file 17: A table listing the genes that encode Smaug-bound
mRNAs annotated as having roles in transcription and/or chromatin.
Additional file 18: A table listing the genes that encode Smaug-bound
mRNAs encoding proteins in the Chaperonin Cpn60/TCP-1 family.
Additional file 19: A table listing the genes that encode Smaug-bound
mRNAs encoding proteins found in the proteasome regulatory particle
and the ubiquitin proteasome pathway.
Additional file 20: A table listing the genes that encode Smaug-bound
mRNAs encoding proteins associated with lipid droplets.
Additional file 21: A table listing the genes that encode Smaug-bound
mRNAs encoding metabolic enzymes.
Additional file 22: A table listing the genes that encode Smaug-bound
mRNAs encoding enzymes involved in glycolysis and related pathways.
Additional file 23: A northern blot that assesses the integrity of
nanos mRNA in polysome gradient pools.Abbreviations
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